A SHORTENED TREATMENT WITH ROSEMARY TEA (ROSMARINUS OFFICINALIS) INSTEAD OF POWDER DECREASES INSULIN RESISTANCE AND SERUM GLUCOSE IN PATIENTS WITH DIABETES MELLITUS TYPE 2 (T2D)
Open Access
- 3 December 2019
- journal article
- research article
- Published by Codon Publications in Journal of Population Therapeutics and Clinical Pharmacology
- Vol. 26 (4) , e18-e28
Abstract
Rosemary leaves powder has been reported to reduce in a dose-dependent manner, glucose levels, lipid profile and lipid peroxidation in humans. However, patients should ingest high doses of powder contained in capsules. This formulation constitutes the intake of 10 capsules per day, so the active metabolite must first, be released and then absorbed (for which, rosemary leaf powder must be mixed with gastric juice). Evaluate whether a shortened dose and time of treatment as well as the pharmaceutical presentation in rosemary tea (Rosmarinus officinalis) instead of powder have a therapeutic effect in the treatment of T2D. The complementary therapy with Rosemary tea (2g/1 litre of water per day) were evaluate on resistance to insulin, oxidative stress, biochemical parameters and anthropometric measurements in forty patients T2D under treatment with metformin and/or glibenclamide afther giving your authorization through informed consent. The data indicated that Rosemary tea intake after 90 days, statistically decreased (p < 0.05) anthropometric parameters like the body mass index and waist-hip ratio. Remarkably, this treatment decreased the percentages of glycated hemoglobin, insulin resistance, and the pancreatic β-cell function and lastly, a significant difference in lipid peroxide levels was found. These data show that shortening time and dose, as well as changing the formulation of the Rosemary plant constitutes a promising treatment for drug-resistant T2D patients.Keywords
This publication has 26 references indexed in Scilit:
- Phenolic compounds from Rosemary (Rosmarinus officinalis L.) attenuate oxidative stress and reduce blood cholesterol concentrations in diet-induced hypercholesterolemic ratsNutrition & Metabolism, 2013
- Inhibition of Gastric Lipase as a Mechanism for Body Weight and Plasma Lipids Reduction in Zucker Rats Fed a Rosemary Extract Rich in Carnosic AcidPLOS ONE, 2012
- The stigma of obesity in the general public and its implications for public health - a systematic reviewBMC Public Health, 2011
- Carnosic acid prevents obesity and hepatic steatosis in ob/ob miceHepatology Research, 2010
- Investigation of the Volatile Fraction of Rosemary Infusion ExtractsScientia Pharmaceutica, 2010
- In vivo assessment of antidiabetic and antioxidant activities of rosemary (Rosmarinus officinalis) in alloxan-diabetic rabbitsJournal of Ethnopharmacology, 2008
- Effects of 50% Ethanol Extract from Rosemary ( Rosmarinus officinalis ) on α‐Glucosidase Inhibitory Activity and the Elevation of Plasma Glucose Level in Rats, and Its Active CompoundJournal of Food Science, 2006
- Liquid chromatograpic–mass spectrometric analysis of phenolics and free radical scavenging activity of rosemary extract from different raw materialJournal of Chromatography A, 2006
- Carnosic Acid and Carnosol, Phenolic Diterpene Compounds of the Labiate Herbs Rosemary and Sage, are Activators of the Human Peroxisome Proliferator-Activated Receptor GammaPlanta Medica, 2006
- Carnosic acid, a new class of lipid absorption inhibitor from sageBioorganic & Medicinal Chemistry Letters, 2004